Latest News and Press Releases

Tryg’s Supervisory Board has today approved the interim report for Q1 2026. Tryg reported a strong insurance service result of DKK 1,655m (DKK 1,540m) and a combined ratio of 84.0% (84.2%) in Q1...

Global specialty chemicals leader Nouryon will introduce its Expancel® 081 microspheres grade at the Pulp and Beyond 2026 event in Helsinki, Finland, from April 15—16, 2026. An innovative bulking...

Dubai, UAE, April 15, 2026 (GLOBE NEWSWIRE) -- Ethereum based crypto Pepeto announces continuous advancement of the Defi tools, tools that aim to revolutionize the whole Defi space, and the signals...

Dubai, UAE, April 15, 2026 (GLOBE NEWSWIRE) -- Pepeto confirmed this week that Binance listing preparations have entered the final phase. Records keep falling in the presale, wallet count doubled...

Schiphol, April 15, 2026 Transaction marks the completion of the strategic review of Aegon UK, further supporting Aegon in its ambition to become a leading US life insurance and retirement group The...

BASEL, Switzerland, April 15, 2026 (GLOBE NEWSWIRE) -- Poster presentations to feature data from clinical asset BV100 addressing carbapenem-resistant Acinetobacter baumannii-calcoaceticus complex...

ROUYN-NORANDA, Quebec, April 15, 2026 (GLOBE NEWSWIRE) -- Abcourt Mines Inc. (“Abcourt” or the “Corporation”) (TSX Venture: ABI) (OTCQB: ABMBF) is pleased to provide an update on development work...

REDWOOD CITY, Calif., April 15, 2026 (GLOBE NEWSWIRE) -- Revolution Medicines, a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today...

WALTHAM, Mass., April 14, 2026 (GLOBE NEWSWIRE) -- Spyre Therapeutics, Inc. (“Spyre” or the “Company”) (Nasdaq: SYRE), a clinical-stage biotechnology company advancing best-in-class antibody...

COPENHAGEN, Denmark, April 14, 2026 (GLOBE NEWSWIRE) -- Arla Foods Ingredients has developed high-protein, nutrient-dense application concepts for users of GLP-1 anti-obesity medications, which it...